Invention Grant
- Patent Title: Heterocyclic sulfonamide derivatives
- Patent Title (中): 杂环磺酰胺衍生物
-
Application No.: US13514208Application Date: 2010-12-07
-
Publication No.: US08614239B2Publication Date: 2013-12-24
- Inventor: Dinesh Chikkanna , Mark Gary Bock , Clive McCarthy , Henrik Moebitz , Chetan Pandit , Ramulu Poddutorri
- Applicant: Dinesh Chikkanna , Mark Gary Bock , Clive McCarthy , Henrik Moebitz , Chetan Pandit , Ramulu Poddutorri
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Scott W. Reid
- Priority: IN3019/CHE/09 20091208
- International Application: PCT/EP2010/069099 WO 20101207
- International Announcement: WO2011/070030 WO 20110616
- Main IPC: A61K31/423
- IPC: A61K31/423 ; A61K31/343 ; C07D263/56 ; C07D307/79
Abstract:
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases (e.g., cancer and inflammation).
Public/Granted literature
- US20120245209A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES Public/Granted day:2012-09-27
Information query
IPC分类:
